Abstract
Methods 63 peanut allergic children (median: age 6 years; peanutspecific IgE 73,5kU/l) who participated in an oral immunotherapy (OIT)-study were enrolled. Data concerning age of diagnosis, provision with self-injectable epinephrine, professional advice and performance of a peanut-free diet as well as the characterization of accidental allergic reactions to peanut (grade of severity I-V) were collected at their baseline visit of the OIT-study.
Highlights
Patients with peanut allergy are advised to strictly avoid peanuts in their diet and to carry an emergency kit including self-injectable epinephrine at all times.The aim of the study was to determine to which extent peanut allergic children in Germany are provided with self-injectable epinephrine and if they had received professional dietary advice
A strict avoidance of peanut was performed by 51/63 families (82%). 12/63 families (18%) did not avoid products labelled with “may contain traces of peanuts”
63 peanut allergic children who participated in an oral immunotherapy (OIT)-study were enrolled
Summary
Patients with peanut allergy are advised to strictly avoid peanuts in their diet and to carry an emergency kit including self-injectable epinephrine at all times. The aim of the study was to determine to which extent peanut allergic children in Germany are provided with self-injectable epinephrine and if they had received professional dietary advice
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
